ATE217614T1 - Neue imidazol-derivate und verfahren zu deren herstellung - Google Patents

Neue imidazol-derivate und verfahren zu deren herstellung

Info

Publication number
ATE217614T1
ATE217614T1 AT95902285T AT95902285T ATE217614T1 AT E217614 T1 ATE217614 T1 AT E217614T1 AT 95902285 T AT95902285 T AT 95902285T AT 95902285 T AT95902285 T AT 95902285T AT E217614 T1 ATE217614 T1 AT E217614T1
Authority
AT
Austria
Prior art keywords
group
lower alkyl
alkyl group
substituent
imidazole derivatives
Prior art date
Application number
AT95902285T
Other languages
English (en)
Inventor
Hiroyuki Miyachi
Kei Okazaki
Hiromi Kiyota
Mitsuru Segawa
Original Assignee
Kyorin Seiyaku Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyorin Seiyaku Kk filed Critical Kyorin Seiyaku Kk
Application granted granted Critical
Publication of ATE217614T1 publication Critical patent/ATE217614T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C07D233/60—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms with hydrocarbon radicals, substituted by oxygen or sulfur atoms, attached to ring nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C07D233/61—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms not forming part of a nitro radical, attached to ring nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/08—Radicals containing only hydrogen and carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Epoxy Resins (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT95902285T 1993-12-10 1994-12-01 Neue imidazol-derivate und verfahren zu deren herstellung ATE217614T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP34146793 1993-12-10
JP31935594A JP3294961B2 (ja) 1993-12-10 1994-11-29 新規イミダゾール誘導体及びその製造法
PCT/JP1994/002021 WO1995015951A1 (fr) 1993-12-10 1994-12-01 Nouveau derive de l'imidazole et sa methode d'obtention

Publications (1)

Publication Number Publication Date
ATE217614T1 true ATE217614T1 (de) 2002-06-15

Family

ID=26569693

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95902285T ATE217614T1 (de) 1993-12-10 1994-12-01 Neue imidazol-derivate und verfahren zu deren herstellung

Country Status (15)

Country Link
US (2) US5932607A (de)
EP (1) EP0733621B1 (de)
JP (1) JP3294961B2 (de)
KR (1) KR100362794B1 (de)
CN (2) CN1069098C (de)
AT (1) ATE217614T1 (de)
AU (1) AU680572B2 (de)
CA (1) CA2178604C (de)
DE (1) DE69430636T2 (de)
DK (1) DK0733621T3 (de)
ES (1) ES2176311T3 (de)
HU (1) HU221950B1 (de)
PT (1) PT733621E (de)
TW (1) TW304193B (de)
WO (1) WO1995015951A1 (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE205490T1 (de) * 1995-10-13 2001-09-15 Banyu Pharma Co Ltd Substituierte heteroaromatische derivate
PE92198A1 (es) * 1996-08-01 1999-01-09 Banyu Pharma Co Ltd Derivados de 1,4-piperidina disustituida que contienen fluor
EP1020449A1 (de) * 1997-09-18 2000-07-19 Mitsubishi-Tokyo Pharmaceuticals, Inc. Imidazolinzusammensetzungen
TW407153B (en) * 1997-10-27 2000-10-01 Nippon Kayaku Kk Imidazole compounds and their use
JP2003286266A (ja) * 1999-03-24 2003-10-10 Mitsubishi-Tokyo Pharmaceuticals Inc イミダゾール化合物
WO2001034147A1 (fr) * 1999-11-11 2001-05-17 Kyorin Pharmaceutical Co., Ltd. Preparation solide orale
JPWO2003027060A1 (ja) * 2001-09-20 2005-05-12 杏林製薬株式会社 ジフェニルブタンアミド誘導体
JP5087059B2 (ja) * 2001-10-31 2012-11-28 杏林製薬株式会社 ４−（２−メチル−１−イミダゾリル）−２，２−ジフェニルブタンアミドの製造方法
CN100364990C (zh) * 2002-10-30 2008-01-30 施万制药 取代的4-氨基-1-(吡啶甲基)哌啶和相关化合物
US20070092566A1 (en) 2003-08-04 2007-04-26 Ryouichi Hoshino Oral sustained-release tablet
JP5548329B2 (ja) * 2003-08-04 2014-07-16 杏林製薬株式会社 経皮吸収型製剤
AR046103A1 (es) * 2003-10-14 2005-11-23 Glaxo Group Ltd Compuesto de 8-azoniabiciclo [3.2.1] octano,composicion farmaceutica para el tratamiento de enfermedades mediadas por receptores de acetilcolina muscarinicos y uso del compuesto para preparar dicha composicion
PE20050489A1 (es) * 2003-11-04 2005-09-02 Glaxo Group Ltd Antagonistas de receptores de acetilcolina muscarinicos
WO2005112644A2 (en) * 2004-05-13 2005-12-01 Glaxo Group Limited Muscarinic acetylcholine receptor antagonists
EP1845091A4 (de) * 2004-12-14 2009-03-04 Kyorin Seiyaku Kk Verfahren zur herstellung eines antagonisten des muskarinrezeptors und zwischenprodukt dafür
EP1844773A4 (de) 2005-02-03 2010-04-28 Kyorin Seiyaku Kk Zubereitung mit perkutaner absorption
JPWO2007013421A1 (ja) * 2005-07-25 2009-02-05 田辺三菱製薬株式会社 新規含窒素ヘテロサイクリック化合物
DK2246051T3 (da) 2008-01-31 2014-01-13 Kyorin Seiyaku Kk Fremgangsmåde til fremstilling af oralt sig hurtigt opløsende tablet omfattende imidafenacin som aktiv bestanddel
CA2713679A1 (en) * 2008-01-31 2009-08-06 Kyorin Pharmaceutical Co., Ltd. Orally rapidly disintegrating tablet comprising imidafenacin
WO2010113952A1 (ja) * 2009-03-31 2010-10-07 杏林製薬株式会社 ムスカリン受容体拮抗薬
ES2604705T3 (es) 2010-03-31 2017-03-08 Ono Pharmaceutical Co., Ltd. Agente preventivo y/o remedio para el síndrome mano-pie
US8748433B2 (en) 2010-04-30 2014-06-10 Merck Sharp & Dohme Corp. β3 adrenergic receptor agonists
CN102746235B (zh) * 2012-07-20 2014-09-03 北京科莱博医药开发有限责任公司 一种改进的制备咪达那新的方法
CN103242230B (zh) * 2013-05-02 2015-02-18 陕西步长高新制药有限公司 一种喹啉酮衍生物及其制备方法
CN103242214B (zh) * 2013-05-02 2016-04-06 陕西步长高新制药有限公司 一种吲哚衍生物及其制备方法
CN112774569B (zh) * 2021-01-11 2022-04-08 江门市华熊新材料有限公司 含氟咪唑表面活性剂及其制备方法与应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4073921A (en) * 1975-03-12 1978-02-14 Rohm And Haas Company Substituted arylcyanoalkyl and diarylcyanoalkylimidazoles and fungical compositions and methods utilizing them
US4225723A (en) * 1975-03-12 1980-09-30 Rohm And Haas Company Process for the preparation of substituted arylcyanoalkyl and diaryl cyanoalkylimidazoles
GB2016452B (en) * 1978-02-18 1982-07-21 Kissei Pharmaceutical Imidazole compounds
JPS6019750B2 (ja) * 1978-02-18 1985-05-17 キツセイ薬品工業株式会社 Ｎ↓−（ω↓−置換アルキル）イミダゾ−ル
JPS6054307B2 (ja) * 1978-06-09 1985-11-29 小野薬品工業株式会社 イミダゾ−ル誘導体
US4293561A (en) * 1979-03-09 1981-10-06 Syntex (U.S.A.) Inc. 1-(Naphthyl-n-propyl)imidazole derivatives
JPS5756464A (en) * 1980-09-22 1982-04-05 Ono Pharmaceut Co Ltd Imidazole derivative ahd inhibitor for biosyntesis of thromboxane a2
US4605661A (en) * 1984-06-18 1986-08-12 Eli Lilly And Company Aromastase inhibiting α,α-diarylimidazole-4(5)-propionitriles, α,α-diarylimidazole-4(5)-propionamides, and 4(5)-(2,2-diarylethyl)imidazoles
US4766140A (en) * 1984-06-18 1988-08-23 Eli Lilly And Company Method of inhibiting aromatase
GB8810067D0 (en) * 1988-04-28 1988-06-02 Ucb Sa Substituted 1-(1h-imidazol-4-yl)alkyl-benzamides
JPH06112670A (ja) * 1992-09-24 1994-04-22 Mitsubishi Rayon Co Ltd 電気機器組立方法

Also Published As

Publication number Publication date
HU221950B1 (hu) 2003-03-28
US6103747A (en) 2000-08-15
CN1069098C (zh) 2001-08-01
EP0733621A1 (de) 1996-09-25
KR960706477A (ko) 1996-12-09
ES2176311T3 (es) 2002-12-01
WO1995015951A1 (fr) 1995-06-15
HU9601505D0 (en) 1996-07-29
AU1120095A (en) 1995-06-27
CN1258673A (zh) 2000-07-05
CA2178604C (en) 2004-06-29
CN1137270A (zh) 1996-12-04
HUT74182A (en) 1996-11-28
JPH07215943A (ja) 1995-08-15
JP3294961B2 (ja) 2002-06-24
AU680572B2 (en) 1997-07-31
EP0733621B1 (de) 2002-05-15
CN1109674C (zh) 2003-05-28
PT733621E (pt) 2002-09-30
EP0733621A4 (de) 1997-04-02
TW304193B (de) 1997-05-01
DE69430636D1 (de) 2002-06-20
KR100362794B1 (ko) 2003-01-29
CA2178604A1 (en) 1995-06-15
DE69430636T2 (de) 2003-01-02
US5932607A (en) 1999-08-03
DK0733621T3 (da) 2002-09-09

Similar Documents

Publication Publication Date Title
DE69430636D1 (de) Neue imidazol-derivate und verfahren zu deren herstellung
DE69433346D1 (de) Verbindungen verwendbar als Zwischenprodukte zur Herstellung von Piperidinderivate
ATE126219T1 (de) Benzimidazolderivate, verfahren zu deren herstellung und anwendung.
DE3785315D1 (de) Erythromycin-a-derivate und verfahren zu ihrer herstellung.
ATE201867T1 (de) N-aminoalkylfluorencarboxamide, neue klasse von dopaminerezeptor subtype spezifische liganden
DE69636439D1 (de) Verfahren zur herstellung von piperidinderivaten
DK0868182T3 (da) Fremgangsmåde til fremstilling af piperidinderivater
TW271435B (de)
ATE233764T1 (de) Tricyclische triazolobenzazepinderivate, verfahren zu ihrer herstellung und antiallergische mittel
ATE41423T1 (de) 1,6-naphthyridinon-derivate, verfahren zu deren herstellung und diese enthaltende arzneimittel.
ATE214061T1 (de) Azetidinonverbindung und verfahren zu ihrer herstellung
DE69319859D1 (de) Neue tetracyclische verbindungen
ATE376830T1 (de) Benzo(b(thiophenderivate und verfahren zu deren herstellung
DE69311500D1 (de) 2,3-Diphenyl-5-pyrrolyl-furan Derivate, Verfahren und Zwischenprodukte für ihre Herstellung und ihre Verwendung als entzündungshemmende, antiallergische und blutplättchenaggregationshemmende Mittel
ATE148128T1 (de) Anthracyclinglycosid-derivate und verfahren zu ihrer herstellung
DE69915471D1 (de) Analoga von distamycin-zimtsäurederivaten, verfahren zu ihrer herstellung und ihre verwendung als antitumormittel
EP0798304A4 (de) Medikamente gegen trhombocytopenie
DE60116655D1 (de) Carbamatderivate, verfahren zu deren herstellung und deren verwendung
TH14340A (th) กรรมวิธีสำหรับเตรียมสารประกอบคาร์แบเพเนมและเพเนมและสารประกอบชนิดใหม่ที่เกี่ยวข้องในกรรมวิธีดังกล่าว
TH14340EX (th) กรรมวิธีสำหรับเตรียมสารประกอบคาร์แบเพเนมและเพเนมและสารประกอบชนิดใหม่ที่เกี่ยวข้องในกรรมวิธีดังกล่าว

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification